Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers N > Headlines for Nymox Pharmaceutical Corp. > News item |
Michael Starcher reports stake of 6.02% in Nymox
By E. Janene Geiss
Philadelphia, Nov. 20 - Investor Michael D. Starcher reported an investment of 6.02% in Nymox Pharmaceutical Corp. as of Oct. 7, according to an SC 13G filing with the Securities and Exchange Commission.
That represents a passive stake of 1,795,000 shares.
Based in Hasbrouck, N.J., Nymox is a biotechnology company focused on needs of the aging population.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.